Brief: Immix Biopharma Completes $5 Million At-The-Market Equity Offering Program
14/06/2023 12:30
June 14 (Reuters) - Immix Biopharma Inc IMMX.O :
* IMMIX BIOPHARMA COMPLETES $5 MILLION AT-THE-MARKET EQUITY
OFFERING PROGRAM
Source text for Eikon: ID:nGNX9wCCZS
Further company coverage: IMMX.O
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary